As reported via the empower study, a 58-year-old female (b)(6) with a history of hypertension and allergic asthma underwent stent-assisted coil embolization of an unruptured middle cerebral artery (mca) aneurysm on (b)(6) 2021.On (b)(6) 2022, the patient experienced stent stenosis, which is still ongoing.The principal investigator assessed the event as mild in severity and as intra-stent stenosis.The relationship between the study device and the procedure was not entered into the crf.The event has not been resolved and the patient has not recovered.No further information was provided.The saccular aneurysm had the following dimensions: maximum aneurysm diameter of 3.5mm and neck width of 3.3mm.The parent vessel diameter was 3.0mm.Stent-assisted coil embolization was successfully performed with the implantation of a 4mm x 16mm enterprise 2 vascular reconstruction device (vrd) (encr401600/5964701) and unspecified coils.There were no reported intraoperative complications or study device deficiencies.The immediate post-procedure assessment showed raymond-roy's score of class i: complete obliteration.A routine neurological examination performed prior to discharge on (b)(6) 2021 revealed a hunt & hess grade 0 and a modified rankin scale (mrs) score of 0.30-day follow-up visit was performed via phone on (b)(6) 2021.Digital subtraction angiography (dsa) is planned for 180 days after the study procedure.
|
Product complaint # (b)(4).Information regarding patient weight, height, race, and ethnicity was not reported.Patient identifier: (b)(6).The device remains implanted, therefore, no further investigation can be performed.Lake region medical did review the device history records relative to the manufacturing, inspecting and packaging of the lot 5964701.The history records indicate this product was final inspection tested at lake region medical and was determined to be acceptable.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
|